As of 2020, the global Covid-19 crisis has created the need for humanity to reshape both the health sector and the relevant economic, political, and cultural areas in order to adapt to this new world. While the production of some medicines for treating the ravages of this pandemic has increased, the development of pharmaceuticals for the treatment of the virus infection as well as vaccine studies for the purpose of protection from the virus have continued intensively. The importance of biotechnological products that require advanced technology, knowledgeable manpower, and costly R&D studies has also increased, and remains understood in this process.

One of the steps to be taken to strengthen the pharmaceutical industry in our country - to become a global player with international competitiveness and playing more roles in foreign markets - is to develop and undertake the production of biological drugs of global standards and quality. With this mission, Viscoran has been established with the aim of responding quickly to the changing needs of the health sector, ensuring that patients are provided biotechnological products at more economical prices, and also to be the production base of Eurasia in high-tech products.

In the Turkish pharmaceutical industry, Viscoran aims to carry out clinical studies, production, sales, marketing and logistics activities concerning biotechnological products, both in regional and international markets, with our team of experienced and knowledgeable experts. In addition, we are excited to offer innovative and unique products such as rapid diagnostic COVID-19 test kits and the supportive agents that are to be used in combination in the treatment of COVID-19 into Turkey and to the foreign markets. We are honored to present you these new, promising, highly anticipated pioneering biotech products.

Best regards,